Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Final thoughts Stopping GHK-Cu typically produces gradual benefit decline over 2-4 months without dramatic rebound effects or rapid reversal to pre-treatment baseline, with 30-40% of long-term users (6+ months treatment) maintaining 50-70% of peak improvements indefinitely while shorter-term users show greater regression toward baseline
Brief virtual consultations may not provide the thorough medical evaluation that in-person visits offer, potentially missing contraindications or underlying health issues that would make GLP-1 use dangerous
Build your protocol using this framework
When stored at -20C, please use it within 6 months
GLP-1 receptor agonists slow gastric emptying, which has been hypothesized to affect pancreatic function, though this connection remains speculative and lacks supporting clinical evidence
US$ 24.88
US$ 23.06
US$ 26.84
US$ 25.10
US$ 21.58
US$ 27.52
US$ 24.76
